Could Ebola trial drug be answer to Covid-19?
India is participating in the trial. Gilead has also started two Phase 3 clinical trials on the safety and efficacy of the drug .
from Hindustan Times - topnews https://ift.tt/2VvVMTw
Labels: Hindustan Times - topnews
posted by Rajesh Pãtidãr @ April 14, 2020
0 Comments
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home